Best Chemotherapy For Prostate Cancer Doctors in Turkey for Australians

Dr Eda Tanrikulu reached third place nationwide in the Turkish medical specialty exam and now leads international clinical trials for cancer therapies at Anadolu Medical Center.

• Specialises in matching chemotherapy protocols to the specific genetic profile of the tumour
• Former Head of Medical Oncology at Haydarpaşa Numune Training and Research Hospital
• Completed advanced oncology training at Oxford University and The Christie in Manchester
• Active member of the American Society of Clinical Oncology and ESMO

Professor Mustafa Solak gained specialised expertise at the MD Anderson Cancer Center in Texas – consistently ranked as one of the world's leading oncology hospitals.

• Specialises in administering hormone therapy and systemic chemotherapy for prostate cancer
• Completed an advanced oncology fellowship at the Hacettepe University Cancer Institute
• Uses targeted therapy and immunotherapy to treat advanced malignancies
• Focuses on evidence-based protocols for complex solid tumours
• Practices at the JCI-accredited Hisar Hospital Intercontinental in Istanbul

Professor Sezer Sağlam is a highly senior medical oncologist at Gayrettepe Florence Nightingale Hospital with a focus on complex drug therapies. He holds a professorship in medical oncology and manages treatment protocols for various advanced solid tumours.

• Trained at Istanbul University, one of Turkey's most prestigious medical institutions
• Member of the American Society of Clinical Oncology (ASCO)
• Full member of the European Society for Medical Oncology (ESMO)
• Specialises in neuroendocrine tumours and gastrointestinal oncology
• Collaborates with the European Neuroendocrine Tumour Society (ENET)

Dr. Sinan Karaaslan is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in treating breast, colorectal, and urogenital system cancers. Dr. Karaaslan brings clinical expertise from major institutions, including Medical Park and Gülhane Military Medical Academy. He works at a hospital affiliated with the Johns Hopkins Hospital.

• Holds personal certification from the European Society for Medical Oncology.
• Treats complex conditions, including stage 4 colon and lung cancers.
• Member of the Turkish Medical Oncology and Turkish Lung Cancer societies.
• Performs systemic therapies such as immunotherapy, targeted therapy, and chemotherapy.

Professor Yesim Yildirim is an ESMO-certified medical oncologist who specialises in targeted therapies and immunotherapy for complex urological cancers. She practices at Anadolu Medical Center, an institution closely affiliated with the prestigious Johns Hopkins Medicine.

• Completed advanced immuno-oncology training at Mount Vernon Cancer Centre in the UK
• Specialises in targeted therapies that attack specific cancer markers while protecting healthy tissue
• Recognised as a Professor with over 80 scientific publications in international medical journals
• Member of the American Society of Clinical Oncology (ASCO)
• Full member of the European Society for Medical Oncology (ESMO)

Dr. Seref Komurcu is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in treating breast, lung, colorectal, and solid cancers. Dr. Komurcu holds both ECFMG and ESMO certifications. He previously served as a professor at Gülhane Military Medical Academy.

• Published over 110 scientific papers on cancer management.
• Provides immunotherapy, targeted therapy, and chemotherapy treatments.
• Member of the American Society of Clinical Oncology.
• Works at a clinic affiliated with Johns Hopkins Medicine.

Dr. Necdet Uskent is a medical oncologist and hematologist at Anadolu Medical Center in Istanbul. He was part of the pioneering team that performed Turkey's first bone marrow transplant. Dr. Uskent holds the European Medical Oncology Certificate and focuses on breast, lung, and gastrointestinal cancers. He works at a facility affiliated with Johns Hopkins Medicine.

• Founder of the Turkish Oncology Group (TOG).
• A founding member of the Turkish Society of Medical Oncology.
• Served as a visiting lecturer at Royal Free and University College Hospital in London.
• Treats complex hematological conditions including lymphomas and myeloma.

Professor Sezer Saglam is a senior medical oncologist at Istanbul Florence Nightingale Hospital with high-level academic standing in complex cancer care.

• Holds the title of Professor of Medical Oncology since April 2016
• Specialises in gastrointestinal oncology and systemic treatments for advanced prostate cases
• Fellowship trained at Istanbul University Oncology Institute
• Active member of the American Society of Clinical Oncology (ASCO)
• Maintains international standards through membership in the European Society for Medical Oncology

Professor Cemil Bilir focuses on the intersection of oncology and biotechnology to provide targeted cancer care at VM Medical Park Pendik Hospital.

• Completed a research fellowship at the Center for Pharmaceutical Biotechnology and Nanomedicine in Boston
• Published extensive research on inorganic chemistry and pharmaceutical biotechnology protocols
• Maintains professional membership with the American Society of Clinical Oncology (ASCO)
• Member of the European Society for Medical Oncology (ESMO)
• Serves as a senior Professor at Sakarya University Faculty of Medicine

Professor Irfan Cicin is a senior medical oncologist who leads the oncology department at Trakya University Faculty of Medicine. He specialises in creating tailored chemotherapy protocols for complex urological malignancies at İstinye University Liv Hospital Topkapı.

• Holds a full professorship at Trakya University training future oncology specialists
• Managed high-volume cases at major Turkish training and research hospitals
• Completed a dedicated fellowship in medical oncology for targeted cancer care
• Fellow of the Department of Medical Oncology at Trakya University

Dr Mustafa Serkan Alemdar is a dual-specialist in internal medicine and medical oncology at the JCI-accredited Medical Park Antalya Hospital Complex.

• Specialised in medical oncology at Akdeniz University Faculty of Medicine
• Expertise includes complex medication management and tailored chemotherapy protocols
• Active member of the Turkish Society of Medical Oncology
• Experienced in treating tumours at a major regional training and research hospital
• Focuses on evidence-based systemic therapies for advanced urological cancers

Professor Ercan Ozden is a dual-specialist in internal medicine and medical oncology at VM Medical Park Pendik Hospital. He manages chemotherapy protocols for complex prostate cancer cases using evidence-based medical oncology standards.

• Specialised in medical oncology at Kocaeli University Faculty of Medicine
• Completed his primary medical degree through the English Medical Programme at Istanbul University
• Holds extensive experience in internal medicine, providing a holistic approach to cancer care
• Focuses on systemic treatments and targeted therapies for urological cancers

Associate Professor Muhammed Mustafa Atci is a leading medical oncologist at Istinye University Liv Hospital Topkapi, specialising in tailored chemotherapy protocols.

• Serves as the Education Coordinator for medical oncology, training the next generation of cancer specialists
• Active member of the American Society of Clinical Oncology (ASCO) since 2018
• Expert in biomarker-driven therapy, having published research on new markers for urological cancer metastasis
• Regular contributor to peer-reviewed international journals on chemotherapy survival outcomes

Uzm. Dr. Erkan Göcen is a Radiation Oncology Specialist at Çerkezköy Private Optimed Hospital (Optimed Health Group). He graduated from İstanbul University, İstanbul Faculty of Medicine (Çapa) in 2003.

Career: He trained and practiced in Radiation Oncology from 2010 to 2012. He worked in public and private health institutions from 2012 to 2016. He served in the private medical sector as a Radiation Oncology Specialist from 2016 to 2023. He has been at Optimed Hospital since 2024.

Clinical interests: cancers of the brain, head and neck, esophagus, stomach, colorectal, pancreas, prostate, bladder, lung, soft tissues (sarcomas), skin, uterus and cervix, and breast. Affiliations: Turkish Society for Radiation Oncology (TROD) and Tekirdağ Medical Chamber. Languages: English and Turkish.

Associate Professor Atakan Topcu is a leading medical oncologist at Medipol Acıbadem Regional Hospital who specialises in treating solid tumours with immunotherapy and targeted therapies.

• Published over 50 scientific articles in international peer-reviewed journals
• Editorial Board Member for the reputable BMC Cancer journal
• Focuses on geriatric oncology and managing cancer-related malnutrition and sarcopenia
• Member of the European Society for Medical Oncology (ESMO)
• Completed a clinical observership at the University of Leicester in the UK

Associate Professor Ayse Irem Yasin is a highly qualified medical oncologist at Medipol Acibadem District Hospital with international training from Harvard Medical School and Cleveland Clinic.

• Holds a prestigious ESMO Board Certificate from Paris
• Specialises in urological cancers including complex prostate cases
• Completed a clinical observership at Basel University Hospital in Switzerland
• Formerly a specialist at Sisli Etfal Training and Research Hospital
• Focuses on targeted systemic therapies and personalised chemotherapy protocols

Associate Professor Nail Paksoy is an ESMO board-certified medical oncologist specialising in advanced prostate cancer treatments and systemic therapies.

• Published research on PSMA-based tumour burden to improve prostate cancer monitoring
• Completed a medical oncology fellowship at the prestigious Istanbul University Oncology Institute
• Subinvestigator for numerous international clinical trials involving immunotherapies and targeted agents
• Recognised as an ESMO Board Certified specialist in Medical Oncology after qualifying in Paris

Prof. Dr. Abdullah Sakin is a professor of medical oncology. He treats solid tumors, including lung, breast, gastrointestinal, genitourinary, gynecologic, head and neck cancers, and melanoma.

He delivers personalized, evidence-based care. His treatments include chemotherapy, targeted therapy, immunotherapy, hormone therapy, and precision oncology. He has authored more than 200 scientific publications and takes part in international clinical research. This work advances patient-centered cancer care.

Prof. Dr. Gül Alço is a radiation oncologist with about 27 years of experience. She treats breast, lung, prostate, gastrointestinal, gynecologic, central nervous system, head and neck, soft tissue, and bone cancers with radiotherapy.

Her expertise includes adaptive radiotherapy and radiosurgery. She uses advanced radiation techniques to provide personalized, evidence-based care in a multidisciplinary, patient-centered setting.